West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript February 13, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceutical Services Inc (WST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 670,878 | $219,752,798 | +1295% | 0.03% |
| 2. | Durable Capital Partners Henry Ellenbogen | 637,398 | $208,786,089 | -42% | 1.7% |
| 3. | D E Shaw D. E. Shaw | 425,915 | $139,512,717 | +5278% | 0.1% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 242,707 | $79,501,105 | +37% | 0.13% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 227,265 | $74,442,923 | +78% | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $105.14 | 54 | 66,251 | 2019-02-28 | Filing | ||
| $110.55 | 57 | 66,197 | 2018-07-31 | Filing | ||
| $93.94 | 335 | 66,475 | 2017-10-17 | Filing | ||
| $88.89 | 275 | 56,540 | 2018-05-15 | Filing | ||
| $84.53 | 332 | 51,831 | 2016-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $310.40 | 225 | Officer | 1,253 | 2024-10-29 | Filing | |
| $310.40 | 478 | Officer | 1,478 | 2024-10-29 | Filing | |
| $300.00 | 500 | Officer | 1,478 | 2024-08-19 | Filing | |
| $300.00 | 529 | Officer | 1,978 | 2024-08-19 | Filing | |
| $365.92 | 617 | Director | 43,565 | 2024-05-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,987,462 | $2,943,933,053 | 0.05% | |
| 2. | 7,450,720 | $2,440,557,908 | 0.04% | |
| 3. | 3,449,811 | $1,130,020,219 | 0.2% | |
| 4. | 3,246,713 | $1,063,534,357 | 0.04% | |
| 5. | 3,110,903 | $1,019,007,387 | 1.53% |
News See All
West Pharmaceutical Services (WST) Bounced Back in Q4
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S.
Should You Sell Your Holdings in West Pharmaceutical Services (WST)?
ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Growth Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
UBS' Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors
With November 2024 having settled in and the US presidential election in its final stages, investors are also digesting the results of the latest earnings season.
West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript October 24, 2024West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceuticals (WST) Fell Due to Industry Headwinds
Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Hold West Pharmaceutical Services (WST) for the Long Term?
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript July 25, 2024West Pharmaceutical Services, Inc. misses on earnings expectations.
Billionaire Hedge Funds
